Now, Organon — Merck’s spin-off business that focuses on women’s health — has launched a campaign celebrating romantasy’s appeal to its target audience. The recently-unveiled campaign supports ...

A still from the "Rromantasy" commercial (Organon) The ad ends with a final nod to the genre, with the claim that Nexplanon is “over 99% effective, no matter the fantasy.” Organon pledges $30M ...

Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in share price following a >90% dividend cut. The company's revenue ...

JERSEY CITY, N.J. - Organon (NYSE:OGN) reported first quarter earnings that beat analyst expectations, but revenue fell short and the company’s guidance disappointed investors, sending shares ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported first-quarter net income of $87 million. The Jersey City, New Jersey-based company said it had net ...

Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company’s webcast ...

Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025. Organon does not forecast IPR&D (in process research and development) or ...

Organon, a women’s health-focused pharma company based in Jersey City, expects to eliminate 93 jobs as part of an effort to optimize internal operations. In a filing with the state Department of ...

This Women’s Month, Organon, dedicated to advancing women’s health at every stage of life, is raising awareness on the preventability and treatability of heart disease, urging women to take ...

TD Cowen analyst Michael Nedelcovych took over primary coverage of Organon (OGN) with a Hold rating and $19 price target Organon presented business updates that provide some insight into the 2025 ...

Cairo, Egypt:Organon, a global healthcare company dedicated to advancing women’s health, announced the signing of a Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This ...